139 related articles for article (PubMed ID: 23180455)
21. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer.
Dexter SP; Sue-Ling H; McMahon MJ; Quirke P; Mapstone N; Martin IG
Gut; 2001 May; 48(5):667-70. PubMed ID: 11302966
[TBL] [Abstract][Full Text] [Related]
22. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
[TBL] [Abstract][Full Text] [Related]
23. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
24. Tumour length as an independent prognostic factor in resectable oesophageal carcinoma.
Vadhwana B; Zosimas D; Lykoudis PM; Phen HM; Martinou M; Khoo D
Ann R Coll Surg Engl; 2020 Mar; 102(3):185-190. PubMed ID: 31755735
[TBL] [Abstract][Full Text] [Related]
25. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
26. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.
Fareed KR; Al-Attar A; Soomro IN; Kaye PV; Patel J; Lobo DN; Parsons SL; Madhusudan S
Br J Cancer; 2010 May; 102(11):1600-7. PubMed ID: 20461087
[TBL] [Abstract][Full Text] [Related]
27. Diverging trends in recent population-based survival rates in oesophageal and gastric cancer.
Lagergren J; Mattsson F
PLoS One; 2012; 7(7):e41352. PubMed ID: 22815994
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
[TBL] [Abstract][Full Text] [Related]
29. Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO).
Söderström HK; Räsänen J; Saarnio J; Toikkanen V; Tyrväinen T; Rantanen T; Valtola A; Ohtonen P; Pääaho M; Kokkola A; Kallio R; Karttunen TJ; Pohjanen VM; Ristimäki A; Laine S; Sihvo E; Kauppila JH
BMJ Open; 2020 Oct; 10(10):e039575. PubMed ID: 33055119
[TBL] [Abstract][Full Text] [Related]
30. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma.
Wu J; Gao FX; Wang C; Qin M; Han F; Xu T; Hu Z; Long Y; He XM; Deng X; Ren DL; Dai TY
J Exp Clin Cancer Res; 2019 Jul; 38(1):321. PubMed ID: 31324197
[TBL] [Abstract][Full Text] [Related]
31. Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy.
France M; Drew PA; Dodd T; Watson DI
Dis Esophagus; 2004; 17(2):136-40. PubMed ID: 15230726
[TBL] [Abstract][Full Text] [Related]
32. A rare case of bipartite combined tumour of the oesophagus.
Goh N; Yeo DXW; Amitbhai SK; Aung MO; Ho YH; Koura AN; Rao J
World J Surg Oncol; 2019 May; 17(1):79. PubMed ID: 31060613
[TBL] [Abstract][Full Text] [Related]
33. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ; Spaander MCW; Valkema R; Wijnhoven BPL; van Berge Henegouwen MI; Shapiro J; Biermann K; van der Gaast A; van Hillegersberg R; Hulshof MCCM; Krishnadath KK; Lagarde SM; Nieuwenhuijzen GAP; Oostenbrug LE; Siersema PD; Schoon EJ; Sosef MN; Steyerberg EW; van Lanschot JJB;
Lancet Oncol; 2018 Jul; 19(7):965-974. PubMed ID: 29861116
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study.
McCain S; Trainor J; McManus DT; McMenamin ÚC; McQuaid S; Bingham V; James JA; Salto-Tellez M; Turkington RC; Coleman HG
Oncotarget; 2018 Sep; 9(76):34347-34356. PubMed ID: 30344947
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.
Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
World J Surg; 2011 Aug; 35(8):1861-6. PubMed ID: 21538187
[TBL] [Abstract][Full Text] [Related]
37. SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway.
Jiang T; Chen ZH; Chen Z; Tan D
Braz J Med Biol Res; 2020; 53(2):e8901. PubMed ID: 32049100
[TBL] [Abstract][Full Text] [Related]
38. HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.
Simpong DL; Asmah RH; Krampah C; Akakpo PK; Adu P; Asante DB; Naporo S; Adjei AA; Gyasi RK
ScientificWorldJournal; 2018; 2018():1564150. PubMed ID: 29725274
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival improvement in oesophageal cancer in the Netherlands.
van Putten M; de Vos-Geelen J; Nieuwenhuijzen GAP; Siersema PD; Lemmens VEPP; Rosman C; van der Sangen MJC; Verhoeven RHA
Eur J Cancer; 2018 May; 94():138-147. PubMed ID: 29571082
[TBL] [Abstract][Full Text] [Related]
40. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
